1	Mitsui	NNP	4	nsubj
2	&	CC	1	cc
3	Co.	NNP	1	conj
4	said	VBD	0	root
5	it	PRP	6	nsubj
6	started	VBD	4	ccomp
7	a	DT	9	det
8	joint	JJ	9	amod
9	venture	NN	6	dobj
10	with	IN	9	prep
11	Dae	NNP	12	nn
12	Woong	NNP	13	nn
13	Chemical	NNP	14	nn
14	Co.	NNP	10	pobj
15	,	,	14	punct
16	a	DT	19	det
17	major	JJ	19	amod
18	pharmaceutical	JJ	19	amod
19	manufacturer	NN	14	appos
20	in	IN	19	prep
21	South	NNP	22	nn
22	Korea	NNP	20	pobj
23	,	,	14	punct
24	to	TO	25	aux
25	manufacture	VB	9	infmod
26	antibiotic	JJ	27	amod
27	medicines	NNS	25	dobj
28	.	.	4	punct

1	The	DT	3	det
2	new	JJ	3	amod
3	company	NN	5	nsubjpass
4	is	VBZ	5	auxpass
5	capitalized	VBN	0	root
6	at	IN	5	prep
7	about	RB	8	quantmod
8	$	$	6	pobj
9	3.5	CD	8	number
10	million	CD	8	number
11	.	.	5	punct

1	Mitsui	NNS	2	nsubj
2	expects	VBZ	0	root
3	the	DT	5	det
4	antibiotic	JJ	5	amod
5	products	NNS	8	nsubjpass
6	to	TO	8	aux
7	be	VB	8	auxpass
8	exported	VBN	2	xcomp
9	to	TO	8	prep
10	Southeast	NNP	11	nn
11	Asia	NNP	9	pobj
12	and	CC	11	cc
13	Africa	NNP	11	conj
14	.	.	2	punct

1	It	PRP	3	nsubj
2	also	RB	3	advmod
3	hopes	VBZ	0	root
4	to	TO	5	aux
5	enter	VB	3	xcomp
6	the	DT	8	det
7	U.S.	NNP	8	nn
8	market	NN	5	dobj
9	.	.	3	punct


